Liumei (06658): Hong Kong's public offering received a subscription of 6586.73 times, raising approximately HK$440 million in net proceeds from the global offering.
Plum Blossom (06658) announced the results of the distribution. The company sold a total of 11.4641 million shares globally, with 10% of the shares available for public sale in Hong Kong and 90% for international sale. The final sale price is HK$43.58 per share, with a net capital raise of approximately HK$440 million from global sales. Trading of H shares is expected to begin on Monday, June 15, 2026 at 9:00 am Hong Kong time on the Stock Exchange.
Plum Blossom (06658) announced the results of the distribution, with a global offering of 11.4641 million shares, 10% of which were offered in Hong Kong and 90% were offered internationally. The final offering price was HK$43.58 per share, with a net fund-raising of approximately HK$440 million. Trading of H shares is expected to begin on June 15, 2026, at 9:00am (Hong Kong time) on the Stock Exchange.
The Hong Kong public offering received 6586.73 times oversubscription, while the international offering received 2.64 times oversubscription.
Related Articles

Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!

RECOMMEND





